Cannabis is a gateway drug and must remain tightly regulated, at least according to Democratic presidential hopeful, Joe Biden during a town hall discussion last Sunday. “The truth of…
November 2019
When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia. Neurodegenerative diseases,…
China is “Cautiously Optimistic” China’s chief negotiator said that he was “cautiously optimistic” about reaching a phase one trade deal with the US despite tensions over Hong Kong. Liu…
No-one likes a braggart – but in Equity Guru’s first four years we’ve represented 120 clients while our website traffic has grown to 50,000 unique monthly readers. During that…
“Resources are coming!” is the yell heard at every Howe Street watering hole lately, and has been for several months. As cannabis bleeds out like traffic stop in Mississippi,…
Let’s not mince words. Graph Blockchain (GBLC.C) has been circling the drain for awhile, flailing about to find something—anything—to grab onto for a lifeline. In April, it was Esports….
Junior exploration companies—ExplorerCos, if you will—are high-risk propositions. It can take up to 1,000 grassroots projects to generate 100 targets worthy of a probe with the drill bit. Of…
Carl Icahn’s Big Short Billionaire Carl Icahn is betting against mall owners. He thinks they will be unable to service their debt. A lot many traders have made the…
Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…
Logistics is not hot. Nobody is telling their assistant, “Bring me the hottest trucking deals out there, I have a hundred grand burning a hole through my pocket and…